Searchable abstracts of presentations at key conferences in endocrinology

ea0073oc4.3 | Oral Communications 4: Reproductive and Developmental Endocrinology | ECE2021

Gender difference in genetic and diagnosis of congenital hypogonadotropic hypogonadism (CHH) in a large cohort from an Endo-ERN referral center

Federici Silvia , Cangiano Biagio , Goggi Giovanni , Persani Luca , Bonomi Marco

Congenital hypogonadotropic hypogonadism (CHH) is a rare condition characterized by impairment of pubertal development, that can be associated with hypo/anosmia (Kallmann Syndrome, KS) or normosmia (nCHH). A genetic basis can be identified in nearly 50% of cases, with increasingly common detection of oligogenicity. CHH has a strong male predominance (MtoF ratio 5–3:1), although sex ratio for CHH in families with autosomal inheritance has been proven to be close to equal....

ea0099ep886 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Physical exercise as a sustainability tool in men affected with metabolic syndrome-related late-onset central hypogonadism: role of endocrine-metabolic and neurovegetative outcomes

Giovanelli Luca , Cangiano Biagio , Federici Silvia , Lucini Daniela , Bonomi Marco

Background: Late-onset central hypogonadism (LOH), whose prevalence is high among dysmetabolic males, impairs quality of life and increases cardiovascular risk. Although lifestyle modification is the first-line therapeutic strategy, it often fails in clinical practice, probably due to socio-cultural, economic and organisational barriers, as well as the lack of effective and sustainable intervention programs.Aim: To delineate sustainable physical exercise...

ea0081p191 | Reproductive and Developmental Endocrinology | ECE2022

FSH and bone: comparison between males with central vs primary hypogonadism

Giovanelli Luca , Cangiano Biagio , Colombo Stefano , Persani Luca , Quinton Richard , Bonomi Marco , Chiodini Iacopo

Background: Recent data suggest a direct effect of follicle stimulating hormone (FSH) on the skeletal metabolism. Particularly, it can encourage bone resorption and also inhibit osteoblast differentiation. High FSH levels have been found to correlate with impaired bone health in females, whilst evidence in males remains somewhat poor and conflicting. Intriguingly, men with primary and central hypogonadism might represent a novel study model in this context.<p class="abstex...

ea0090p143 | Pituitary and Neuroendocrinology | ECE2023

Role of fT4 and TSH-index fluctuations as early diagnostic tools in milder forms of central hypothyroidism: data from 221 patients with pituitary lesions from a single tertiary center

Carrara Silvia , Galazzi Elena , Nicoli Federico , Moro Mirella , Fatti Letizia , Cangiano Biagio , Persani Luca

Diagnosis of Central Hypothyroidism (CeH) is commonly given when FT4 concentrations are below the lower limit of normal range. A reduction in FT4 concentrations greater than 20% was proposed in ETA 2018 Guidelines as an unphysiological fluctuation indicating the onset of milder forms of CeH with FT4 still within the normal range. Similarly, TSH-index was proposed to quantify thyrotrope reserve, hence as a tool to detect patients at risk of CeH. Here we verified the performance...

ea0070aep807 | Reproductive and Developmental Endocrinology | ECE2020

Genetic background and previous androgenization are associated with reproductive and non-reproductive outcomes of Gonadotropin-mediated pubertal induction in Congenital Hypogonadotropic Hypogonadism (CHH)

Cangiano Biagio , Goggi Giovanni , Federici Silvia , Guizzardi Fabiana , Vezzoli Valeria , Duminuco Paolo , Persani Luca , Bonomi Marco

CHH is a rare disease with a relevant genetic background, and is characterized by a failure to enter (complete forms) or to complete (partial forms) pubertal development. It requires a treatment to allow the completion of puberty, and in male this goal can be achieved either using testosterone replacement therapy or administering gonadotropins (Gn); the latter allows both testicular development and the endogenous testosterone production. There are few studies evaluating the th...

ea0056oc12.3 | Novel aspects of puberty development and Cushing's disease | ECE2018

Evaluation of genetic predisposition in severe and mild phenotypes of isolated hypogonadotropic hypogonadism

Cangiano Biagio , Duminuco Paolo , Vezzoli Valeria , Guizzardi Fabiana , Persani Luca , Bonomi Marco

Introduction: Isolated hypogonadotropic hypogonadism (IHH) often occurs in the pre-pubertal period but it can also manifest in post-puberal age. Recent position statements and guidelines differentiate between a ‘true’ hypogonadotropic hypogonadism, intended as congenital or acquired organic defect (characterized by frankly pathological total Testoterone values, TTe <3.5 nmol/l), and a ‘false’ or functional hypogonadism, associated to older age and comor...

ea0099p269 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Study of genetic predisposition and other pathogenetic mechanisms underlying hypogonadotropic hypogonadism in type 2 diabetes mellitus

Cangiano Biagio , Amodeo Alessandro , Lunati Elena , Vezzoli Valeria , Galazzi Elena , Persani Luca , Fiorina Paolo , Bonomi Marco

Background: In patients affected by type 2 diabetes mellitus (T2DM) a high prevalence of hypogonadotropic hypogonadism (HH) has been reported, even if there is no consensus on its pathogenic mechanisms. In addition to acquired causes, an individual predisposition has also been suggested. The understanding ofPurpose: The aim of this observational study is to assess: (1) the prevalence of hypogonadism in T2DM using the validated criteria from the EMAS stud...

ea0081ep869 | Reproductive and Developmental Endocrinology | ECE2022

Procoagulant imbalance in male hypogonadism and effect of short-term testosterone replacement therapy

Indirli Rita , Clerici Marigrazia , Lanzi Valeria , Profka Eriselda , Cangiano Biagio , Bonomi Marco , Arosio Maura , Mantovani Giovanna , Tripodi Armando , Ferrante Emanuele

Introduction: The effects of testosterone on coagulation have not yet been clarified. In particular, it is still controversial whether male hypogonadism, or testosterone replacement therapy (TRT), may slightly increase the risk of venous thromboembolism, in particular during the first months of therapy. This study aimed to assess the hemostatic balance in hypogonadal men before and after short-term TRT, compared to healthy controls.Methods: Thrombin gene...

ea0090p67 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Study of the prevalence, clinical correlates, and cardiovascular outcomes of central and primary hypogonadism in type 2 diabetes mellitus

Cangiano Biagio , Elena Lunati Maria , Bollino Ruggiero , Conti Antonio , Galazzi Elena , Fiorina Paolo , Persani Luca , Bonomi Marco

Background: In patients affected with type 2 diabetes mellitus (T2DM) a high prevalence of hypogonadism has been reported, even if there is no consensus on its metabolic and cardiovascular implications, especially according to the type of hypogonadism. The aim of this observational study is to evaluate: (1) the prevalence of different types of hypogonadism in T2DM according to validated criteria from the EMAS study; (2) look for correlations of gonadal status with severity or ...

ea0081rc12.7 | Rapid Communications 12: Reproductive and Developmental Endocrinology | ECE2022

Pubertal induction in girls with hypogonadism: insight into estrogen replacement therapy outcomes and optimization of progesterone introduction

Rodari Giulia , Federici Silvia , Cattoni Alessandro , Todisco Tommaso , Ubertini Graziamaria , Giacchetti Federico , Profka Eriselda , Dall'Antonia Alberta , Cangiano Biagio , Arosio Maura , Bonomi Marco , Cappa Marco , Giavoli Claudia

Background: Pubertal induction in girls with hypogonadism through estrogen replacement therapy (ERT) aims at mimicking physiological puberty. To date, the best induction regimen is still to be established.Aims: By setting up a multicentre clinical registry, we analysed longitudinal data on pubertal induction in girls with hypogonadotropic hypogonadism or premature ovarian insufficiency (congenital, acquired, isolated or associated with multiple pituitary...